X23-10-ZQ524 |
IKK/IκB inhibitor MRT67307, Purity ≥98%
|
|
X23-10-ZQ637 |
IKK/IκB inhibitor CDDO-EA, Purity ≥98%
|
|
X23-10-ZQ752 |
IKK/IκB inhibitor BMS-345541 HCl, Purity ≥98%
|
|
X23-10-ZQ753 |
IKK/IκB inhibitor Bardoxolone methyl, Purity ≥98%
|
|
X23-10-ZQ754 |
IKK/IκB inhibitor Bardoxolone, Purity ≥98%
|
|
X23-10-ZQ755 |
IKK/IκB inhibitor Bay 65-1942 HCl, Purity ≥98%
|
|
X23-10-ZQ756 |
IKK/IκB inhibitor Bay 65-1942, Purity ≥98%
|
|
X23-10-ZQ757 |
IKK/IκB inhibitor IKK-2 inhibitor VIII, Purity ≥98%
|
|
X23-10-ZQ758 |
IKK/IκB inhibitor IKK-3 Inhibitor, Purity ≥98%
|
|
X23-10-ZQ759 |
IKK/IκB inhibitor TPCA-1, Purity ≥98%
|
|
X23-10-ZQ760 |
IKK/IκB inhibitor Bay 11-7821, Purity ≥98%
|
|
X23-10-ZQ761 |
IKK/IκB inhibitor BAY 11-7085, Purity ≥98%
|
|
X23-10-ZQ762 |
IKK/IκB inhibitor BMS-345541, Purity ≥98%
|
|
X23-10-ZQ763 |
IKK/IκB inhibitor SC-514, Purity ≥98%
|
|
X23-10-ZQ764 |
IKK/IκB inhibitor PS-1145, Purity ≥98%
|
|
X23-10-ZQ765 |
IKK/IκB inhibitor IKK-16, Purity ≥98%
|
|
X23-10-ZQ766 |
IKK/IκB inhibitor IMD 0354, Purity ≥98%
|
|
X23-10-ZQ767 |
IKK/IκB inhibitor WS3, Purity ≥98%
|
|
X23-10-ZQ768 |
IKK/IκB inhibitor WS6, Purity ≥98%
|
|
X23-10-ZQ769 |
IKK/IκB inhibitor PHA 408, Purity ≥98%
|
|
X23-10-ZQ770 |
IKK/IκB inhibitor BI605906, Purity ≥98%
|
|
X23-10-ZQ776 |
IKK/IκB inhibitor Bay 65-1942 R form, Purity ≥98%
|
|
X23-10-ZQ778 |
IKK/IκB inhibitor MLN120B, Purity ≥98%
|
|
X23-10-ZQ780 |
IKK/IκB inhibitor LY2409881, Purity ≥98%
|
|
X23-10-ZQ781 |
IKK/IκB inhibitor AZD3264, Purity ≥98%
|
|
X23-10-ZQ783 |
IKK/IκB inhibitor Amlexanox, Purity ≥98%
|
|
X23-10-ZQ784 |
IKK/IκB inhibitor IKK epsilon-IN-1, Purity ≥98%
|
|
X23-10-ZQ790 |
IKK/IκB inhibitor TBK1/IKKε-IN-5, Purity ≥98%
|
|
X23-10-ZQ791 |
IKK/IκB inhibitor INH14, Purity ≥98%
|
|
X23-10-ZQ793 |
IKK/IκB inhibitor IKK-IN-1, Purity ≥98%
|
|
X23-10-ZQ794 |
IKK/IκB inhibitor IKK 16 hydrochloride, Purity ≥98%
|
|